Table 3. Stratification analysis for the association between rs11134527 A>G polymorphism and Kawasaki disease susceptibility.
| Variables | AA/AG | GG | Crude OR (95% CI) | P | Adjusted OR* (95% CI) | P* |
|---|---|---|---|---|---|---|
| cases/controls | ||||||
| Age, month | ||||||
| <12 | 110/145 | 22/20 | 1.45 (0.75–2.79) | 0.266 | 1.51 (0.78–2.94) | 0.221 |
| 12–60 | 279/331 | 68/66 | 1.22 (0.84–1.78) | 0.293 | 1.22 (0.84–1.78) | 0.297 |
| >60 | 40/47 | 4/14 | 0.34 (0.10–1.10) | 0.072 | 0.26 (0.07–0.94) | 0.041 |
| Gender | ||||||
| Females | 130/189 | 35/32 | 1.59 (0.94–2.70) | 0.086 | 1.56 (0.91–3.67) | 0.104 |
| Males | 299/334 | 59/68 | 0.97 (0.66–1.42) | 0.873 | 0.98 (0.67–1.43) | 0.907 |
| Coronary artery lesion | ||||||
| CAL | 140/523 | 26/100 | 0.97 (0.61–1.55) | 0.904 | 0.97 (0.61–1.56) | 0.912 |
| NCAL | 289/523 | 68/100 | 1.23 (0.88–1.73) | 0.232 | 1.23 (0.87–1.73) | 0.237 |
*
Adjusted for age and gender.